← SynDRA
LOMETREXOL
SynDRA canonical compound SYN0001913 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | GART |
|---|
| Mechanism of action | glycinamide ribonucleotide formyltransferase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- glycinamide ribonucleotide formyltransferase inhibitor
Drug classes
- Antimetabolites, Antineoplastic
- Folic Acid Antagonists
Cross-references
Synonyms
- LY264618
- Lometrexolum
- 5,10-dideazatetrahydrofolic acid
- 6P3AVY8A7Q
- 5,10-dideazatetrahydrofolate
- 5,10-Dideaza-5,6,7,8-tetrahydrofolic acid
- NSC660025
- 5,10-DDTF
- RefChem:800022
- (6R)-DDATHF
- 6R-5,10-Dideazatetrahydrofolate
- Pyrido(2,3-d)pyrimidine, L-glutamic acid derivative
- DDATHF
- Lometrexol [INN:BAN]
- Lometrexolum [INN-Latin]
- UNII-6P3AVY8A7Q
- DDATHF-B
- LY-264618
- LOMETREXOL [INN]
- LOMETREXOL [WHO-DD]
- SCHEMBL18530
- orb1707028
- SCHEMBL17520098
- BDBM22590
- C21H25N5O6
- GEA40081
- MFCD00866319
- AKOS040741996
- CCG-222045
- NCGC00485206-01
- NCGC00485206-02
- DA-75070
- HY-14521
- MS-27983
- T-64
- CS-0003423
- NS00070452
- G12728
- BRD-K66036108-001-01-9
Look up LOMETREXOL in the interactive SynDRA portal →